John Hayslip
Chief Tech/Sci/R&D Officer presso VERASTEM, INC.
Profilo
John Hayslip is currently the Chief Medical Officer at Verastem, Inc. He previously worked as the Director-Clinical Research & Data Management at The Markey Cancer Center Foundation and as the Vice President-Clinical Development at Nektar Therapeutics.
From 2022 to 2024, he served as the Chief Medical Officer at I-Mab.
Dr. Hayslip holds a graduate degree from the Medical University of South Carolina and a doctorate degree from Northeast Ohio Medical University.
Posizioni attive di John Hayslip
| Società | Posizione | Inizio |
|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 18/04/2024 |
Precedenti posizioni note di John Hayslip
| Società | Posizione | Fine |
|---|---|---|
| I-MAB | Chief Tech/Sci/R&D Officer | 15/04/2024 |
| The Markey Cancer Center Foundation | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Formazione di John Hayslip
| Medical University of South Carolina | Graduate Degree |
| Northeast Ohio Medical University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| VERASTEM, INC. | Health Technology |
| I-MAB | Health Technology |
| Aziende private | 1 |
|---|---|
| The Markey Cancer Center Foundation |
- Borsa valori
- Insiders
- John Hayslip
